News
- No news available
Press Releases
Clear effect in pre-clinical study
Sangair team can share some exciting news. Our ongoing pre-clinical study shows a clear effect. SangAspet™ lowers the number of…
Sangair patent is approved in Canada
The intellectual property family has expanded with an approved patent application in Canada, pertaining to ozonation of blood, and more…
Sangair strengthens the board of Directors
At the annual bord meeting on the 16th of June the shareholders added two new board members, Susanne Olausson and…